| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,202,700 | 1,218,900 | 966,500 | 360,600 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 1,202,700 | 1,218,900 | 966,500 | 360,600 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 923,800 | 894,200 | 896,700 | 892,500 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,500 | 2,600 | 2,500 | 4,300 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 275,400 | 322,100 | 67,300 | (536,200) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 275,400 | 322,100 | 67,300 | (536,200) | | Interest Expense | 17,100 | 18,300 | 18,900 | 20,600 | | Income Before Tax | 258,300 | 303,800 | 48,400 | (556,800) | | Income Tax Expense | 73,900 | 88,600 | 12,300 | (311,600) | | Minority Interest | (83,300) | 6,700 | (6,700) | 34,000 | | | | Net Income From Continuing Ops | 109,400 | 230,500 | 30,300 | (212,600) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 109,400 | 230,500 | 30,300 | (212,600) | | Preferred Stock And Other Adjustments | 50,200 | (50,200) |
-
|
-
| | | Net Income Applicable To Common Shares | $159,600 | $180,300 | $30,300 | ($212,600) |
|
0.11% Nasdaq 
0.01%
Income Statement
